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A patient was colonized by IMP-4-producing Enterobacter cloacae and Escherichia coli strains for 7 months. IMP-4-producing E.
cloacae strains were first and last isolated at day 33 and at 8 months after admission, respectively. IMP-4-producing E. coli
strains were first and last isolated at days 88 and 181 after admission, respectively. The E. cloacae and E. coli isolates shared iden-
tical genetic features in terms of blaIMP-4, blaTEM-1, qnrB2, aacA4, HI2 plasmids, and ISCR1. This study shows the first prolonged
colonization with in vivo interspecies transfer of blaIMP-4.
CASE REPORT
A52-year-old Australian female patient suffered 60% burnswith inhalational injury in May 2013. The patient underwent
multiple debridements and allografts with several episodes of sep-
sis. She was hospitalized continuously for 8months. Multiple sus-
ceptible organisms, including Enterococcus faecalis, Serratia marc-
escens, Escherichia coli, and Pseudomonas aeruginosa, were isolated
from the patient. Additionally, Stenotrophomonas maltophilia
strains were isolated from this patient. (Consent to use all isolates
for molecular analysis was provided by the patient.) The S. malto-
philia strains were resistant to -lactam antibiotics, including
carbapenems; however, they remained susceptible to trimethoprim-
sulfamethoxazole.Thepatient receivedvariousantibiotics, including
amikacin, cefepime, ciprofloxacin, co-trimoxazole, gentamicin,
meropenem, piperacillin-tazobactam, and vancomycin as pro-
phylaxis at the time of debridement as well as for the treatment of
sepsis.
At 33 days after hospitalization, a meropenem-resistant En-
terobacter cloacae strain was isolated from the tracheal aspirate.
The meropenem resistance of E. cloacae was determined with the
Vitek 2 system (bioMérieux, Victoria, Australia). Meropenem-
resistant E. cloacae strains were isolated on 10 occasions during a
7-month hospitalization period from tracheal aspirates, rectal
swabs, and wound specimens, four of which were available for
analysis. Simultaneous meropenem-resistant E. cloacae isolates
were obtained from rectal swabs and wounds during sepsis epi-
sodes at the fourth month of hospitalization.
On the 88th day of hospitalization, a meropenem-resistant E.
coli strain was isolated from urine. Meropenem-resistant E. coli
strains were isolated on nine consecutive occasions from rectal
swabs and urine fromday 88 until day 181 of hospitalization. Four
E. coli isolates from 1 urine specimen and 3 rectal swabs were
available for analysis. A total of 30meropenem-resistant P. aerugi-
nosa strains were isolated from different body sites, including
blood, rectal swabs, wound swabs, and tracheal aspirates. Seven P.
aeruginosa strains were included for analysis. The first mero-
penem-resistant P. aeruginosa strain was isolated on day 28 after
admission. P. aeruginosa and Candida albicanswere isolated from
blood during sepsis episodes in June and August 2013.
Antibiotic susceptibility testing of all E. cloacae, E. coli, and P.
aeruginosa strains by the Vitek 2 system (bioMérieux, Victoria,
Australia) showed resistance to ertapenem, meropenem, imi-
penem, ceftazidime, cefotaxime, cefoxitin, cefepime, piperacillin-
tazobactam, and ciprofloxacin according to the EUCAST stan-
dard (1). In addition, the E. cloacae and E. coli strains were also
resistant to gentamicin and tobramycin. They remained suscepti-
ble to amikacin. The E. cloacae and E. coli strains showed carbap-
enemase production on a modified Hodge test using carbapenem
discs and by the Carba NP test (2, 3). The MICs of meropenem
tested by Etest (bioMérieux) ranged from 2 to 8 mg/liter for E.
cloacae and from 4 to 8 mg/liter for E. coli.
Four E. cloacae, four E. coli, and seven P. aeruginosa strains
were analyzed for clonal relatedness using appropriate kits of the
Diversilab repetitive-sequence-based PCR (rep-PCR) system
(bioMérieux) following the manufacturer’s instructions (4). The
E. cloacae strains were clonally related, showing97% similarities
(Fig. 1A). All E. coli strains were also clonally related, with96%
similarities (Fig. 1B). All P. aeruginosa strains from various spec-
imens were identical by Diversilab rep-PCR (data not shown).
Phenotypic and genotypic characterization was used to deter-
mine the antibiotic resistance mechanisms. PCR and sequencing
were performed to determine the genes encoding resistance to
-lactams and aminoglycosides (5–7). Plasmid-mediated quino-
lone resistance (PMQR) was determined as previously described
(8). The plasmid replicon and the insertion element associated
with the carbapenemase-encoding gene were also identified by
previously describedmethods (9, 10). PCR and sequencing deter-
mined the presence of blaIMP-4, blaTEM-1, qnrB2, aacA4, and ISCR1
in all meropenem-resistant E. cloacae and E. coli strains isolated
from this patient.None of theP. aeruginosa strainswas positive for
blaIMP-4. HI2 plasmids were detected in E. cloacae and E. coli. Plas-
mid multilocus sequencing was performed for both HI2 plasmids
using the scheme from http://pubmlst.org/plasmid/. The se-
quence type of both HI2 plasmids was ST1. The sequence results
using primers to target the entire integron class 1 showed that the
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blaIMP-4 gene and aacA4 (aminoglycoside resistance gene) were
located inside the class 1 integron (11). The composition of the
sequence inside this class 1 integron was 5=-intI1-blaIMP-4-aacA4-
3=. This blaIMP-4 genetic region in our isolates was similar to the
previously reported blaIMP-4 region from Taiwan (12). Conjuga-
tion experiments were performed using the IMP-4-producing E.
cloacae isolate (EclI) and E. coli isolate (Ec1), the first two IMP-4-
producing Enterobacteriaceae isolates from this patient. The
blaIMP-4-harboring H12 plasmids were transferred into an E. coli
K-12 strain by liquid mating and screening on MacConkey agar
supplemented with 150 g/ml ampicillin. The blaTEM-1, aacA4,
and qnrB2 genes were located in the blaIMP-4-harboring H12 plas-
mids. The identical key genetic features of IMP-4-producing E.
cloacae and E. coli strains showed that the in vivo transfer of the
blaIMP-4-carrying plasmid had occurred from E. cloacae to E. coli.
This horizontal plasmid transfer was potentially induced by pro-
longed antibiotic treatment. The MICs of meropenem and cipro-
floxacin of the E. coli K-12 strains acquiring blaIMP-4-harboring
plasmids from the two donors were both 4 and 0.5 mg/liter, re-
spectively. The initial MICs to meropenem and ciprofloxacin of
the E. coli K-12 strain prior to the conjugation experiment were
0.02 and 0.004 mg/liter, respectively. The ciprofloxacin MICs of
the two donor or clinical strains were32 mg/liter. The increase
in themeropenem and ciprofloxacinMICs of the transconjugants
was due to the acquisition of plasmids harboring blaIMP-4 and
qnrB2.
The sequence type of IMP-4-producing E. coliwas determined
using the scheme from http://mlst.warwick.ac.uk/mlst/dbs/Ecoli:
the ST was ST744. The IMP-4-producing E. coli belonged to phy-
logenetic group A, the commensal group of E. coli (13). This
ST744 was also identified as phylogenetic group A (14). To con-
firm whether the patient was still colonized with the IMP-4-pro-
ducing Enterobacteriaceae, a rectal swab and a fecal specimenwere
collected in the 8th month after admission (day 238 of hospital-
ization), prior to patient discharge. An IMP-4-producing E. cloa-
cae strain was isolated from feces. No IMP-4-producing E. coli
strain was isolated from the final rectal swab and fecal specimen.
The IMP-4-producing E. cloacae strain from feces (Ec4) was iden-
tical to other previous E. cloacae isolates from this patient, as de-
termined by Diversilab rep-PCR (Fig. 1A). The patient was still
colonized in the gastrointestinal tract with IMP-4-producing E.
cloacae, but at low numbers, as evidenced by the fact that the
organism was not detected by rectal swab.
IMP-producing Enterobacteriaceae are themost commonly re-
ported carbapenemase-producing Enterobacteriaceae (CPE) in
Australia (15–17). The emergence of IMP-4-producing Entero-
bacteriaceae in both sporadic and outbreak-like situations has
been reported in Australia over the past few years (15–17). Out-
break-like situations caused by IMP-4 producers have been re-
ported due to contaminated equipment or environment (18). The
mechanism of spread of IMP-producing Enterobacteriaceae in
sporadic cases has not been elucidated. Espedido and colleagues
had shown in vitro transfer of plasmids harboring blaIMP-4 from
various strains of Enterobacteriaceae into laboratory strains of E.
coli (15).We report an interspecies transfer of the blaIMP-4 plasmid
FIG 1 Dendrograms of IMP-4-producing E. cloacae (A) and E. coli (B).
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from E. cloacae into E. coli within a patient in Australia. In total,
this patient had colonization by two species of IMP-4 producers
for 7 months.
Most of the reported cases or outbreaks by IMP-producing
Enterobacteriaceae in hospitals in Asia were by Klebsiella pneu-
moniae and Enterobacter cloacae in China (19, 20). In China and
Taiwan, IMP producers were initially more prevalent than other
types of CPE. Recently KPC-producing K. pneumoniae have been
reported to bemore prevalent and to be causing outbreaks in these
two countries (19, 21).
Following the identification of IMP-producing Enterobacteri-
aceae in this patient, rigorous screening forCPEwas performed on
other patients within the same ward and hospital environment.
No CPE was found from other patients or the hospital environ-
ment. Therefore, the initial source of IMP producers in this pa-
tient remained unknown. Strict infection control measures have
been consistently adhered to in this hospital. Examples of these
preventive measures include use of isolation rooms for burn pa-
tients, thorough regular cleaning of the burn unit, and strict clean-
ing of the bathroom after each patient. This case illustrates further
emergence of IMP-4-producing E. cloacae and the potential
spread of IMP-4 to E. coli.
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